tradingkey.logo
tradingkey.logo
Search

Bausch + Lomb Corp

BLCO
Add to Watchlist
16.540USD
-0.090-0.54%
Close 06/30, 16:00ETQuotes delayed by 15 min
5.86BMarket Cap
LossP/E TTM

More Details of Bausch + Lomb Corp Company

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corp Info

Ticker SymbolBLCO
Company nameBausch + Lomb Corp
IPO dateMay 06, 2022
CEOSaunders (Brenton L)
Number of employees13500
Security typeOrdinary Share
Fiscal year-endMay 06
Address520 Applewood Crescent
CityVAUGHAN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryCanada
Postal codeL4K 4B4
Phone19082552864
Websitehttps://ir.bausch.com/
Ticker SymbolBLCO
IPO dateMay 06, 2022
CEOSaunders (Brenton L)

Company Executives of Bausch + Lomb Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

FAQs

Who are the top five shareholders of Bausch + Lomb Corp?

The top five shareholders of Bausch + Lomb Corp are: Mr. Luc Bonnefoy

How many institutions hold shares of Bausch + Lomb Corp (BLCO)?

As of 2026Q1, 249 institutions hold shares of Bausch + Lomb Corp, with a combined market value of approximately 40.30M, accounting for 11.30% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -25007155.00.

What is the biggest source of revenue for Bausch + Lomb Corp?

In 2026Q1, the Devices business generated the highest revenue for Bausch + Lomb Corp, amounting to 1.92B and accounting for 37.68% of total revenue.
KeyAI